Pyrido-pyrimidinone and pteridinone compounds and methods of use
US12344603B2 · kind B2 · utility
0Cited by
6References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2021 |
| Grant date | Jul 1, 2025 |
| Priority date | — |
| Expiry date | Jan 1, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D475/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are pyrido-pyrimidinone and pteridinone compounds or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods treating cancer, alone and in combination with other therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.